Total Payments
$1.2M
2024 Payments
$66,552
Companies
50
Transactions
2,837
Medicare Patients
12,446
Medicare Billing
$2.2M
Payment Breakdown by Category
Other$981,558 (79.4%)
Travel$101,432 (8.2%)
Consulting$82,920 (6.7%)
Food & Beverage$70,175 (5.7%)
Education$179.51 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $981,558 | 498 | 79.4% |
| Travel and Lodging | $101,432 | 568 | 8.2% |
| Consulting Fee | $82,920 | 37 | 6.7% |
| Food and Beverage | $70,175 | 1,720 | 5.7% |
| Education | $179.51 | 14 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $316,470 | 521 | $0 (2024) |
| Lilly USA, LLC | $187,782 | 331 | $0 (2024) |
| Amarin Pharma Inc. | $151,103 | 403 | $0 (2023) |
| Novo Nordisk Inc | $150,749 | 150 | $0 (2024) |
| Amgen Inc. | $130,290 | 329 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $118,780 | 262 | $0 (2024) |
| Boston Scientific Corporation | $94,966 | 209 | $0 (2024) |
| CVRx, Inc. | $36,165 | 67 | $0 (2024) |
| SANOFI PASTEUR INC. | $15,007 | 11 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $10,793 | 118 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $66,552 | 180 | Lilly USA, LLC ($21,218) |
| 2023 | $105,646 | 273 | Lilly USA, LLC ($33,615) |
| 2022 | $101,286 | 309 | Boehringer Ingelheim Pharmaceuticals, Inc. ($29,438) |
| 2021 | $75,227 | 269 | Boehringer Ingelheim Pharmaceuticals, Inc. ($31,902) |
| 2020 | $138,777 | 306 | Boehringer Ingelheim Pharmaceuticals, Inc. ($40,469) |
| 2019 | $254,090 | 550 | Lilly USA, LLC ($55,080) |
| 2018 | $298,491 | 502 | Novo Nordisk Inc ($95,364) |
| 2017 | $196,195 | 448 | Boehringer Ingelheim Pharmaceuticals, Inc. ($61,917) |
All Payment Transactions
2,837 individual payment records from CMS Open Payments — Page 1 of 114
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,040.00 | General |
| Category: Diabetes | ||||||
| 12/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: Respiratory | ||||||
| 12/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.73 | General |
| Category: DIABETES | ||||||
| 12/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,125.00 | General |
| Category: DIABETES | ||||||
| 12/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Travel and Lodging | In-kind items and services | $91.44 | General |
| Category: DIABETES | ||||||
| 12/03/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $23.61 | General |
| Category: Cardiology | ||||||
| 11/25/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $20.68 | General |
| Category: Respiratory | ||||||
| 11/25/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/20/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $118.71 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 11/20/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/18/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $24.61 | General |
| Category: Heart Failure | ||||||
| 11/18/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $2.20 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/15/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $23.63 | General |
| Category: Heart Failure | ||||||
| 11/13/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $33.35 | General |
| Category: DIABETES | ||||||
| 10/31/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $30.11 | General |
| Category: DIABETES | ||||||
| 10/30/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $124.77 | General |
| Category: DIABETES | ||||||
| 10/28/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $34.80 | General |
| Category: DIABETES | ||||||
| 10/21/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $121.33 | General |
| Category: Diabetes | ||||||
| 10/21/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $22.39 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/16/2024 | ATRICURE, INC. | ATRICLIP LAA EXCLUSION SYSTEM (Device) | Food and Beverage | In-kind items and services | $126.58 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/09/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $23.44 | General |
| Category: Heart Failure and Hypertension | ||||||
| 10/03/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $6.62 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 09/26/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $33.89 | General |
| Category: DIABETES | ||||||
| 09/18/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: Cardiology | ||||||
| 09/17/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $23.14 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 30 | 2,889 | 4,920 | $724,144 | $534,935 |
| 2022 | 37 | 3,305 | 5,029 | $788,220 | $585,774 |
| 2021 | 36 | 3,122 | 5,030 | $764,660 | $581,118 |
| 2020 | 37 | 3,130 | 4,867 | $681,666 | $513,831 |
Total Patients
12,446
Total Services
19,846
Medicare Billing
$2.2M
Procedure Codes
140
All Medicare Procedures & Services
140 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 365 | 1,417 | $209,551 | $152,911 | 73.0% |
| 93229 | Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | Office | 2023 | 72 | 76 | $76,620 | $61,113 | 79.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 254 | 265 | $63,409 | $46,914 | 74.0% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 167 | 172 | $50,658 | $38,046 | 75.1% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 90 | 91 | $47,471 | $37,966 | 80.0% |
| 93978 | Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | Office | 2023 | 155 | 157 | $34,981 | $26,609 | 76.1% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 146 | 149 | $35,221 | $26,601 | 75.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 195 | 365 | $38,169 | $21,636 | 56.7% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 32 | 296 | $29,340 | $19,484 | 66.4% |
| 93975 | Complete ultrasound of abdomen and pelvis artery and vein blood flow | Office | 2023 | 64 | 66 | $22,335 | $16,288 | 72.9% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 90 | 182 | $17,645 | $13,732 | 77.8% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 59 | 62 | $15,163 | $10,577 | 69.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 60 | 60 | $8,877 | $8,902 | 100.3% |
| 94621 | Test for exercise-induced heart and lung stress | Office | 2023 | 56 | 56 | $10,569 | $7,480 | 70.8% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 102 | 105 | $8,582 | $6,706 | 78.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 318 | 516 | $9,123 | $6,482 | 71.0% |
| 95800 | Sleep study including heart rate, breathing, and sleep time | Office | 2023 | 34 | 37 | $6,516 | $5,165 | 79.3% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 70 | 87 | $9,083 | $5,113 | 56.3% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Office | 2023 | 27 | 218 | $6,457 | $5,085 | 78.7% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 68 | 69 | $4,655 | $3,582 | 76.9% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 68 | 69 | $4,462 | $3,570 | 80.0% |
| 93224 | Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | Office | 2023 | 36 | 36 | $3,097 | $2,264 | 73.1% |
| 94375 | Test to measure rate of airflow | Office | 2023 | 55 | 55 | $2,586 | $1,869 | 72.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 15 | 15 | $2,893 | $1,848 | 63.9% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2023 | 72 | 76 | $2,206 | $1,769 | 80.2% |
About Dr. Ronald D'agostino, D.O
Dr. Ronald D'agostino, D.O is a Cardiovascular Disease healthcare provider based in Lake Success, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1831134865.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ronald D'agostino, D.O has received a total of $1.2M in payments from pharmaceutical and medical device companies, with $66,552 received in 2024. These payments were reported across 2,837 transactions from 50 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($981,558).
As a Medicare-enrolled provider, D'agostino has provided services to 12,446 Medicare beneficiaries, totaling 19,846 services with total Medicare billing of $2.2M. Data is available for 4 years (2020–2023), covering 140 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Lake Success, NY
- Active Since 06/16/2006
- Last Updated 08/01/2014
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1831134865
Products in Payments
- JARDIANCE (Drug) $483,450
- Vascepa (Drug) $151,103
- Repatha (Biological) $129,374
- XARELTO (Drug) $119,503
- Ozempic (Drug) $78,214
- WATCHMAN (Device) $68,982
- Victoza (Drug) $62,684
- Barostim Neo System (Device) $36,165
- WATCHMAN Access System (Device) $21,488
- FLUZONE HIGH-DOSE (Biological) $14,907
- PRADAXA (Drug) $13,267
- BRILINTA (Drug) $5,043
- DISEASE STATE (Drug) $4,628
- EPANOVA (Drug) $3,247
- Roszet (Drug) $2,819
- ENTRESTO (Drug) $2,242
- Reveal LINQ (Device) $2,215
- CardioInsight (Device) $1,529
- THERAPIES (Device) $1,523
- LOTUS EDGE (Device) $1,500
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Lake Success
Kenneth Cohen, M.d, M.D
Cardiovascular Disease — Payments: $76,499
Cardiovascular Disease $76,499
Dr. Kunal Chawla, Md, MD
Cardiovascular Disease — Payments: $19,941
Cardiovascular Disease $19,941
Henry Gomez, M.d, M.D
Cardiovascular Disease — Payments: $19,725
Cardiovascular Disease $19,725
Louis Gleckel, Md, MD
Cardiovascular Disease — Payments: $14,087
Cardiovascular Disease $14,087
Daniel Appelbaum, Md, MD
Cardiovascular Disease — Payments: $4,094
Cardiovascular Disease $4,094
Marie Roethel, Md, MD
Cardiovascular Disease — Payments: $2,906
Cardiovascular Disease $2,906